News
Moderna MRNA kicked off 2025 with mixed first-quarter results. While its streamlining efforts improved bottom-line numbers, the steep decline in revenues raises concerns. While sales of its COVID ...
Moderna is being audited by the PMCPA after yet again being found to have brought discredit on the pharma industry, putting the company on a path that could lead to its suspension from U.K. trade ...
As a result, Moderna's shares have suffered, falling more than 90% since their peak in 2021. Now let's consider where Moderna will be a few years from now. The company recently said it aims to ...
Side effects were injection site pain, fatigue and headaches. Moderna previously reported a summary of the results from the company-sponsored trial in 8,000 people. The mRNA technology is used in ...
A little over a month after announcing her departure from Moderna, Kate Cronin has begun her “next adventure.” Cronin has joined Medtronic Diabetes as chief marketing officer, a company ...
Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against COVID-19 and most strains of flu than existing ...
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators want to see data on whether the new vaccine protects people from getting ...
Just over a month after leaving Moderna, Kate Cronin has a new healthcare leadership gig. Cronin, a 2020 MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results